We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
-6.21%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$3.96B
AUM Growth
-$1.21B
Cap. Flow
-$814M
Cap. Flow %
-20.57%
Top 10 Hldgs %
65.22%
Holding
51
New
5
Increased
12
Reduced
15
Closed
15

Top Buys

Rank Stock Value
1
ALIT icon
Alight
ALIT
+$104M
2
CNC icon
Centene
CNC
+$80.3M
3
GTM
ZoomInfo Technologies
GTM
+$64.7M
4
DNB
Dun & Bradstreet
DNB
+$62.6M
5
MYGN icon
Myriad Genetics
MYGN
+$53.4M

Top Sells

Rank Stock Value
1
CTVA icon
Corteva
CTVA
+$188M
2
CI icon
Cigna
CI
+$134M
3
MRVL icon
Marvell Technology
MRVL
+$84M
4
DXC icon
DXC Technology
DXC
+$69.3M
5
MCK icon
McKesson
MCK
+$64.6M

Sector Composition

Rank Sector Weight
1 Healthcare 47.33%
2 Technology 18.91%
3 Industrials 14.66%
4 Consumer Discretionary 6.7%
5 Materials 4.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WCC
51
WESCO International
WCC
$17.7B
– –
-274,794
Closed -$46.2M
1 2
3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return

Glenview Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Glenview Capital Management held 51 positions worth $3.96B, down 23% from $5.17B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Glenview Capital Management withdrew a net $814M in Q4 2024, closing 15 positions and reducing 15 holdings. Its most notable exit was Marvell Technology, an estimated $84M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 43% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glenview Capital Management opened a new position in Centene worth $78M.

  • Glenview Capital Management's largest Q4 2024 buy was Centene: 1,287,341 shares worth $78M.
  • Glenview Capital Management added most to Alight in Q4 2024, an estimated $104M increase.
  • Glenview Capital Management's biggest Q4 2024 reduction was Corteva, cutting an estimated $188M.
  • Glenview Capital Management fully exited Marvell Technology in Q4 2024, selling an estimated $84M.
  • Glenview Capital Management's ten largest holdings make up 65% of its $3.96B portfolio in Q4 2024.
  • Glenview Capital Management opened 5 new positions and closed 15 in Q4 2024.
  • Glenview Capital Management's portfolio value fell 23% quarter-over-quarter to $3.96B.

Based on Glenview Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.